ANDA 209583, held by Breckenridge. Teriflunomide.
As of Nov 16, 2026, ANDA 209583 (Teriflunomide), held by Breckenridge, was first approved by FDA on Sep 24, 2021, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 24, 2021 | Original application | Approved | None posted |
| Teriflunomide7MG · tablet;oral | Teriflunomide | Discontinued |
| Teriflunomide14MG · tablet;oral | Teriflunomide | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters